/주식/CGTX
CGTX

CGTX

USD

Cognition Therapeutics Inc. Common Stock

$0.317+0.002 (0.698%)

실시간 가격

Healthcare
생명공학
미국

가격 차트

Loading Chart...

핵심 지표

시장 지표
기업 기본 정보
거래 통계

시장 지표

시가

$0.315

고가

$0.315

저가

$0.306

거래량

0.54M

기업 기본 정보

시가총액

19.7M

산업

생명공학

국가

United States

거래 통계

평균 거래량

1.07M

거래소

NCM

통화

USD

52주 범위

저가 $0.222현재가 $0.317고가 $2.535

관련 뉴스

GlobeNewswire

Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies

Dr. James Galvin of the University of Miami to Serve as Lead Investigator First Site Initiated: Banner Sun Health Research Institute PURCHASE, N.Y., June 03, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc.,

더 보기
Philanthropic Donor Funds Cognition Therapeutics' Expanded Access Program for Zervimesine (CT1812) in Dementia with Lewy Bodies
GlobeNewswire

Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies

PURCHASE, N.Y., May 28, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the "Company" or "Cognition") (NASDAQ:CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, has released

더 보기
Cognition Therapeutics Releases New Episode of "Conversations" Podcast: Studying the Patient/Caregiver Lived Experience in Dementia with Lewy Bodies
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3

HC Wainwright & Co. analyst Raghuram Selvaraju maintains Cognition Therapeutics with a Buy and lowers the price target from $5 to $3.

더 보기
HC Wainwright & Co. Maintains Buy on Cognition Therapeutics, Lowers Price Target to $3